4//SEC Filing
Leproust Emily M. 4
Accession 0001214659-25-015764
CIK 0001581280other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:05 PM ET
Size
13.0 KB
Accession
0001214659-25-015764
Insider Transaction Report
Form 4
Leproust Emily M.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-10-30$31.44/sh−31,379$986,691→ 738,809 total
Holdings
- 64,950
Employee Stock Option (right to buy)
Exercise: $67.85From: 2022-12-19Exp: 2030-08-31→ Common Stock (64,950 underlying) - 0
Employee Stock Option (right to buy)
Exercise: $5.95Exp: 2025-09-28→ Common Stock (0 underlying) - 150,879
Employee Stock Option (right to buy)
Exercise: $8.82Exp: 2027-09-28→ Common Stock (0 underlying) - 266,539
Employee Stock Option (right to buy)
Exercise: $26.66Exp: 2028-11-18→ Common Stock (0 underlying) - 131,290
Employee Stock Option (right to buy)
Exercise: $23.33Exp: 2029-10-23→ Common Stock (0 underlying)
Footnotes (6)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F4]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F5]25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F6]Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753655
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 4:05 PM ET
- Size
- 13.0 KB